[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100453460":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":21,"centralContacts":21,"locations":21,"responsibleParty":25,"collaborators":21,"id":27,"slug":28,"hasResults":29,"nctId":30,"briefTitle":31,"officialTitle":31,"acronym":21,"eligibilityCriteria":32,"healthyVolunteers":29,"sex":33,"minAge":34,"maxAge":35,"enrollmentInfo":36,"targetDuration":21,"studyType":39,"phases":40,"briefSummary":42,"conditions":43,"keywords":21,"overallStatus":46,"whyStopped":21,"lastUpdateSubmitDate":47,"lastUpdatePostDateStruct":48,"startDateStruct":51,"completionDateStruct":53,"leadSponsor":55,"locationsCount":21},{"fullName":5,"class":6},"Shanghai Zhongshan Hospital","OTHER",[8,13],{"label":9,"type":10,"description":9,"interventionNames":11},"systemic lymph node dissection group","ACTIVE_COMPARATOR",[12],"Other: Systemic Lymph Node Dissection",{"label":14,"type":15,"description":14,"interventionNames":16},"selective lymph node dissection","EXPERIMENTAL",[17],"Other: selective lymph node dissection",[19,22],{"type":6,"name":14,"description":14,"armGroupLabels":20,"otherNames":21},[14],null,{"type":6,"name":23,"description":23,"armGroupLabels":24,"otherNames":21},"Systemic Lymph Node Dissection",[9],{"type":26,"investigatorFullName":21,"investigatorTitle":21,"investigatorAffiliation":21,"oldNameTitle":21,"oldOrganization":21},"SPONSOR","100453460","a-single-center-study-on-the-effect-of-systemicselective-lymph-node-dissection-on-the-prognosis-of-ground-glass-nodules-smaller-than-3cm-and-with-components-with-consolidationtumor-ratio-between-05-1-100453460",false,"NCT05184829","A Single-center Study on the Effect of Systemic\u002FSelective Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With Components With Consolidation\u002FTumor Ratio Between 0.5-1","Inclusion Criteria:\n\nPatients enrolled in the study must meet all of the following conditions:\n\n* 1.Aged between 25 and 75 years;\n* 2\\. GGO is diagnosed by thin-section lung CT (thickness \\\u003C1.5mm) within one month before surgery;\n* 3\\. The maximum diameter of the GGO is smaller than 3cm;\n* 4\\. The solid component in GGO between 50%-100%;\n* 5\\. Preoperative examination showed that the patient could tolerate lobectomy;\n* 6\\. The patient is able to understand and comply with the study and has provided written informed consent.\n\nExclusion Criteria:\n\nPatients meeting any of the following criteria are not eligible for this trial:\n\n* 1\\. Patients with a history of lung surgery;\n* 2\\. Postoperative pathology showed non-primary lung cancer;\n* 3\\. The scope of surgical resection is larger than one lung lobe;\n* 4\\. Patients with a history of other tumors;\n* 5\\. Patients with severe complications (coronary heart disease, valvular heart disease, end-stage renal disease, severe liver cirrhosis);\n* 6\\. Unable to cooperate with the researchers because of dementia or cognitive decline\n* 7\\. Other situations that are not in conformity with the standards and requirements of this trial.","ALL","25 Years","75 Years",{"count":37,"type":38},500,"ESTIMATED","INTERVENTIONAL",[41],"NA","A single-center study on the effect of systemic\u002Fselective lymph node dissection on the prognosis of ground glass nodules smaller than 3cm and with components with consolidation\u002Ftumor ratio between 0.5-1",[44,45],"Progression","Postoperative Recovery","NOT_YET_RECRUITING","2021-12-28",{"date":49,"type":50},"2022-01-11","ACTUAL",{"date":52,"type":38},"2022-01-01",{"date":54,"type":38},"2029-12-31",{"name":5,"class":6}]